Why Avery Dennison (AVY) is a Top Momentum Stock for the Long-Term

Avery Dennison shares rose 10% over the past four weeks, and four analysts raised fiscal 2026 earnings estimates in the last 60 days. The Zacks consensus estimate increased by $0.01 to $10.17 per share, while the company’s average earnings surprise is +6.7%. Zacks rates AVY #3 (Hold), with B scores for both Momentum and VGM.

Analysis

This is a momentum-screen promotion, not a fresh fundamental catalyst. The signal is internally modest: AVY remains a Zacks #3 (Hold), and the cited FY2026 consensus increase is only $0.01 to $10.17 despite four upward revisions. That may indicate improving breadth, but not yet a meaningful change in the earnings trajectory. The reported four-week share gain also raises the risk that a short-term momentum trade is already partly priced in.

The more durable thesis would require evidence that demand and mix across labels, materials and related identification products are supporting organic growth and margins—not simply estimate drift or past earnings beats. If volumes weaken or input-cost recovery/pricing falters, operating leverage could work in reverse; the article provides no segment data to test this. In the near term, further estimate revisions and the next earnings report matter more than the score. Over 6–18 months, sustained volume growth, margin resilience and cash conversion would validate a structural long; the article does not establish those conditions.

Contrarian read: the “long-term” framing overstates what is essentially a short-horizon momentum screen. Avoid chasing the recent move absent valuation context and confirmation in operating metrics. The thesis weakens if estimates turn down, guidance or organic growth disappoints, or the recent advance reverses on elevated selling volume.

Key Decisions for Investors

• Do not initiate a long solely on this article. Treat AVY as a watchlist name; verify current valuation, organic sales growth, segment margins, cash conversion and the breadth and magnitude of estimate revisions.
• For a tactical long, wait for the next earnings update or another round of upward revisions to confirm fundamentals are catching up with price. Keep risk defined against a break below the recent consolidation or momentum support; no price level is supplied here.
• If already long, consider trimming into strength rather than adding after the reported four-week rally unless guidance and operating metrics confirm durable acceleration.
• Reassess the thesis if FY2026 estimates roll over, organic growth or margins disappoint, or management commentary points to weaker customer demand or less effective input-cost recovery.